Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study Meeting Abstract


Authors: Yoshino, T.; Kim, T. W.; Yong, W. P.; Shiu, K. K.; Vittrup Jensen, B.; Henrik Jensen, L; Smith, D.; Garcia-Carbonero, R.; Alcaide-Garcia, J.; Gibbs, P.; de la Fouchardiere, C.; Rivera, F.; Elez, E.; Bendell, J.; Le, D. T.; Yang, P.; Farooqui, M.; Marinello, P.; Diaz, L. A.; Andre, T.
Abstract Title: Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study
Meeting Title: ESMO Asia Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 6
Meeting Dates: 2020 Nov 20-22
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-11-01
Start Page: S1284
End Page: S1285
Language: English
ACCESSION: WOS:000600988900113
DOI: 10.1016/j.annonc.2020.10.132
PROVIDER: wos
Notes: Meeting Abstract: 112P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Luis Alberto Diaz
    154 Diaz